Short Interest in ALPS Medical Breakthroughs ETF (NYSEARCA:SBIO) Increases By 74.3%

ALPS Medical Breakthroughs ETF (NYSEARCA:SBIO) was the target of a large increase in short interest during the month of August. As of August 14th, there was short interest totaling 78,401 shares, an increase of 74.3% from the July 30th total of 44,970 shares. Approximately 2.5% of the company’s shares are sold short. Based on an average daily trading volume, of 37,830 shares, the days-to-cover ratio is currently 2.1 days.

ALPS Medical Breakthroughs ETF Trading Down 2.1%

SBIO traded down $1.38 during trading on Monday, reaching $65.71. 14,559 shares of the company’s stock were exchanged, compared to its average volume of 37,750. ALPS Medical Breakthroughs ETF has a one year low of $34.66 and a one year high of $70.85. The firm has a fifty day moving average price of $65.70 and a two-hundred day moving average price of $57.17.

Institutional Inflows and Outflows

A number of large investors have recently made changes to their positions in SBIO. Bank of America Corp DE lifted its stake in ALPS Medical Breakthroughs ETF by 63.1% in the first quarter. Bank of America Corp DE now owns 98,679 shares of the company’s stock worth $5,165,000 after purchasing an additional 38,193 shares during the last quarter. Moran Wealth Management LLC grew its stake in shares of ALPS Medical Breakthroughs ETF by 39.2% during the first quarter. Moran Wealth Management LLC now owns 29,348 shares of the company’s stock valued at $1,536,000 after buying an additional 8,264 shares during the last quarter. Harbor Investment Advisory LLC purchased a new position in shares of ALPS Medical Breakthroughs ETF in the second quarter worth about $29,000. Independent Financial Group LLC purchased a new position in shares of ALPS Medical Breakthroughs ETF in the first quarter worth about $283,000. Finally, Sterling Investment Advisors Ltd. lifted its stake in shares of ALPS Medical Breakthroughs ETF by 50.1% in the 1st quarter. Sterling Investment Advisors Ltd. now owns 22,025 shares of the company’s stock valued at $1,153,000 after acquiring an additional 7,350 shares during the last quarter.

ALPS Medical Breakthroughs ETF Company Profile

The ALPS Medical Breakthroughs ETF (SBIO) is an exchange-traded fund that is based on the S-Network Medical Breakthroughs index. The fund tracks, a market-cap weighted index comprising US-listed biotech companies with one or more drugs currently in either Phase II or Phase III FDA clinical trials. SBIO was launched on Dec 31, 2014 and is managed by ALPS.